Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Intimation under Regulation 30 of SEBI (LODR) Regulations 2015: Business Expansionmore...
Intimation of Award Received: Recognition as Fastest Growing Ethical Pharma Companymore...
Intimation of Investor Presentation under Regulation 30 of SEBI (LODR) Regulations 2015more...
As of December 2025 72.89% is owned by Indian Promoters and 27.11% by Public. Top five Promoters holding highest number of shares of Aptus P...more...
Compliance Certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018more...
Intimation pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 regarding Press release - Aptus Pharma expands OTC presence in Guja...more...
Regulation 30 Disclosure - Entry into the Urology Therapy Segmentmore...
Submission of Monitoring Agency report for the period ended 30th September. 2025.more...
Intimation of new product- ENZYKING SYRUPmore...
Intimation of new product- SHIROVITA HAIR OIL (AYURVEDIC HAIR OIL)more...
Unaudited Financial Results for the Half Year Ended on 30th September 2025more...
Unaudited Financial Results for the half year ended on 30th September 2025more...
Board Meeting Outcome for Approval Of Unaudited Financial Results For The Half Year Ended on 30th September 2025more...
Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 inter alia to consider...more...
take on record clarification for price movementmore...
As of September 2025 72.89% is owned by Indian Promoters and 27.11% by Public. Top five Promoters holding highest number of shares of Aptus ...more...
The Exchange has sought clarification from Aptus Pharma Ltd on October 17 2025 with reference to significant movement in price in order to ensure tha...more...
Trading Members of the Exchange are hereby informed that effective from September 30 2025 the equity shares of Aptus Pharma Ltd (Scrip Code: 544529) ...more...
BOARD MEETINGS Company Name : Biogen Pharmachem Date : 23-03-2026